Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04828317
Other study ID # HSR200447
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 1, 2021
Est. completion date April 30, 2024

Study information

Verified date March 2021
Source University of Virginia
Contact Jeffrey Wilson, MD, PhD
Phone 434-243-8674
Email jmw2gc@virginia.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study is investigating the hypothesis that alpha-gal is responsible for the gastrointestinal symptoms that occur in some alpha-gal syndrome subjects following the consumption of mammalian meat. This will be tested by comparing symptoms and immune responses in subjects with alpha-gal syndrome following consumption of "wild-type" pork (which contains alpha-gal) versus consumption of a novel pork product which has been genetically modified to lack alpha-gal (GalSafe pork from Revivicor Inc.).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 54
Est. completion date April 30, 2024
Est. primary completion date April 30, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: Alpha-gal cases: - Age 18-70 - Patient report of episodic GI symptoms within past 6 months that correlated with ingestion of mammalian meat and/or dairy and which improved on a mammalian avoidance diet. - IgE to a-Gal >0.1 IU/mL at screening visit. - Willingness and ability to comply with scheduled visits and study procedures. Control subjects: - Age 18-70 - Regularly consume/tolerate mammalian meat without obvious associated gastrointestinal or skin symptoms. - Have eaten mammalian meat within the past 2 weeks - Willingness and ability to comply with scheduled visits and study procedures. Exclusion Criteria: Alpha-gal cases: - History of anaphylaxis that was or could have been attributed to mammalian meat in the estimation of the PI. - IgE to pork which exceeds the value of IgE to a-Gal on screening test - Unexplained, persistent urticaria or pruritis. - Pregnancy, breastfeeding or lack of birth control in women of child-bearing age. - At the discretion of the principal investigator, patients may be excluded due to poorly controlled chronic gastrointestinal conditions including but not limited inflammatory bowel disease (i.e., Crohn's disease, ulcerative colitis, microscopic colitis), acid reflux/heartburn, history of bariatric surgery or gastric banding, active peptic ulcer disease or any abdominal surgery within the past 2 months. - Patient is unable to swallow food or has poor peripheral access. - Patient has any medical or physiological disorder or condition that, in the opinion of the Investigator, would compromise the well-being of the patient or study or prevent the patient from meeting or performing study requirements. Control subjects: - History of anaphylaxis that was or could have been attributed to mammalian meat in the estimation of the PI - Unexplained, persistent urticaria or pruritis. - Poorly controlled chronic gastrointestinal problem - Patient is unable to swallow food or has poor peripheral access - Patient has any medical or physiological disorder or condition that, in the opinion of the Investigator, would compromise the well-being of the patient or study or prevent the patient from meeting or performing study requirements.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Pork Challenge
Double blind oral challenges comparing wild-type and alpha-gal free pork.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Virginia

Outcome

Type Measure Description Time frame Safety issue
Primary Composite GI symptom score GI symptoms will be assessed using modified FAST diary. Score is determined from a survey of five gastrointestinal symptoms obtained at 0,1,3,5 hours following oral pork challenge. Symptoms are measured via numerical rating scale (1-5) and aggregate score will be calculated. Score is calculated from survey of gastrointestinal symptoms between 1 and 5 hours after challenge. .
Secondary Tryptase Serum tryptase levels (ng/mL) will be quantified with ImmunoCap comparing post-challenge levels with baseline. Serial samples from 0 to 5 hours post-challenge
Secondary Histamine/Methyl-histamine Histamine and methyl-histamine (ng/mL) from serum and urine samples will be quantified with ELISA comparing post-challenge to baseline. Serial samples from 0 to 6 hours post-challenge
Secondary 11Beta-PGF2-alpha 11Beta-PGF2-alpha (pg/mL), a PGD2 metabolite, will be quantified in serum and urine with ELISA comparing post-challenge to baseline Serial samples from 0 to 6 hours post-challenge
See also
  Status Clinical Trial Phase
Completed NCT04604912 - Biomarkers in Food Allergy Diagnosis
Suspended NCT03352856 - Food Challenge With Barley Starch as Active Comparator N/A
Recruiting NCT06069492 - Randomized Controlled Trial for Wheat Oral Immunotherapy N/A
Completed NCT04519827 - A Hypoallergenicity Study on a New Rice-Based Hydrolysate Formula N/A
Not yet recruiting NCT05826405 - Efficacy and Safety of Oral Cashew Nut Immunotherapy in Children (CAJESITO)
Active, not recruiting NCT03667651 - The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants Phase 3
Terminated NCT03504774 - Food Allergen OIT for Shrimp and Cashew Phase 2
Completed NCT04400214 - The Food Allergy Superheroes Training (FAST) Program N/A
Not yet recruiting NCT06167564 - Allergy Diagnostic Test Based on Microchip Technology N/A
Completed NCT04774796 - Group CBT Intervention for Parents of Children With Food Allergy N/A
Completed NCT03861910 - Dietary Choice for the Management of Cow's Milk Allergy Influences Other Allergic Manifestations
Recruiting NCT05407012 - TRANS-FOODS: Preventing Peanut Allergy Through Improved Understanding of the Transcutaneous Sensitisation Route, Novel Food Processing and Skin Care Adaptations N/A
Not yet recruiting NCT04329078 - Relevance of Sensitization to Legumes in Children Allergic to Peanut